| 1 |
Horvath I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease[J]. Eur Respir J, 2017, 49(4): 1600965.
|
| 2 |
Mahr TA, Malka J, Spahn JD. Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice[J]. Allergy Asthma Proc, 2013, 34(3): 210-219.
|
| 3 |
Ludviksdottir D, Diamant Z, Alving K, et al. Clinical aspects of using exhaled NO in asthma diagnosis and management[J]. Clin Respir J, 2012, 6(4): 193-207.
|
| 4 |
Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5): 602-615.
|
| 5 |
李江华，李 力，王玉波，等. 呼出气一氧化氮和血嗜酸性粒细胞对哮喘患者气道高反应性程度的预测价值[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(1): 24-30.
|
| 6 |
蔡柏蔷，李龙芸. 协和呼吸病学．第2版[M]. 中国协和医科大学出版社，2011: 413-420.
|
| 7 |
Kim HB, Eckel SP, Kim JH, et al. Exhaled NO: Determinants and clinical application in children with allergic airway disease[J]. Allergy Asthma Immunol Res, 2016, 8(1): 12-21.
|
| 8 |
Manna A, Montella S, Maniscalco M, et al. Clinical application of nasal nitric oxide measurement in pediatric airway diseases[J]. Pediatr Pulmonol, 2015, 50(1): 85-99.
|
| 9 |
Logotheti H, Pourzitaki C, Tsaousi G, et al. The role of exhaled nitric oxide in patients with chronic obstructive pulmonary disease undergoing laparotomy surgery-The noxious study[J]. Nitric Oxide, 2016, 61: 62-68.
|
| 10 |
Klinger JR, Kadowitz PJ. The nitric oxide pathway in pulmonary vascular disease[J]. Am J Cardiol, 2017, 120(8S): S71-S79.
|
| 11 |
Bjermer L, Alving K, Diamant Z, et al. Current evidence and future research needs for FeNO measurement in respiratory diseases[J]. Respir Med, 2014, 108(6): 830-841.
|
| 12 |
中国医师协会呼吸医师分会. 无创气道炎症评估支气管哮喘的临床应用中国专家共识[J]. 中华结核和呼吸杂志，2015, 38(5): 329-341.
|
| 13 |
Malinovschi A, Backer V, Harving H, et al. The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms[J]. Respir Med, 2012, 106(6): 794-801.
|
| 14 |
Alving K, Malinovschi A. Basic aspects of exhaled nitric oxide[J]. Eur Respir Monograph, 2011, 49: 1-31.
|
| 15 |
Prieto L, Ruiz-Jimenez L, Marin J. The effect of spirometry on bronchial and alveolar nitric oxide in subjects with asthma[J]. J Asthma, 2013, 50(6): 623-628.
|
| 16 |
Romero KM, Robinson CL, Baumann LM, et al. Role of exhaled nitric oxide as a predictor of atopy[J]. Respir Res, 2013, 14: 48.
|
| 17 |
Global strategy for asthma management and prevention 2019 update .2019.
URL
|
| 18 |
李志伟，马千里，王长征. 支气管哮喘的炎症表型及其临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(4): 41-45.
|
| 19 |
Mcnicholl DM, Stevenson M, Mcgarvey LP, et al. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma[J]. Am J Respir Crit Care Med, 2012, 186(11): 1102-1108.
|
| 20 |
Menzella F, Lusuardi M, Galeone C, et al. Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential[J]. Ther Adv Chronic Dis, 2016, 7(6): 260-277.
|
| 21 |
Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma[J]. N Engl J Med, 2011, 365(12): 1088-1098.
|
| 22 |
Corcuera-Elosegui P, Sardon-Prado O, Aldasoro-Ruiz A, et al. Inflammatory patterns in asthmatic children based on alveolar nitric oxide determination[J]. Arch Bronconeumol, 2015, 51(6): 279-284.
|
| 23 |
Muraro A, Lemanske RJ, Hellings PW, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the european academy of allergy and clinical immunology and the american academy of allergy, asthma & immunology[J]. J Allergy Clin Immunol, 2016, 137(5): 1347-1358.
|
| 24 |
Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases[J]. Lancet, 2018, 391(10118): 350-400.
|
| 25 |
Magni C, Chellini E, Zanasi A. Cough variant asthma and atopic cough[J]. Multidiscip Respir Med, 2010, 5(2): 99-103.
|
| 26 |
Kim SH, Jeong JH, Kwak HJ, et al. Measurement of nasal nitric oxide is useful for the diagnosis of sinusitis-induced prolonged cough[J]. Tohoku J Exp Med, 2011, 223(2): 145-151.
|
| 27 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health[CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
|
| 28 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 29 |
Martinez FD. Early-life origins of chronic obstructive pulmonary disease[J]. N Engl J Med, 2016, 375(9): 871-878.
|
| 30 |
Lazar Z, Kelemen A, Galffy G, et al. Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease[J]. J Breath Res, 2018, 12(3): 36017.
|
| 31 |
Santus P, Radovanovic D, Mascetti S, et al. Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD[J]. Pharmacol Res，2018，133：160-169.
|
| 32 |
Alcazar-Navarrete B, Castellano MF, Santiago DP, et al. Alveolar and bronchial nitric oxide in chronic obstructive pulmonary disease and asthma-COPD overlap[J]. Arch Bronconeumol, 2018, 54(8): 414-419.
|
| 33 |
Shapiro AJ, Davis SD, Polineni D, et al. Diagnosis of primary ciliary dyskinesia. an official american thoracic society clinical practice guideline[J]. Am J Respir Crit Care Med, 2018, 197(12): e24-e39.
|
| 34 |
Lucas JS, Barbato A, Collins SA, et al. European respiratory society guidelines for the diagnosis of primary ciliary dyskinesia[J]. Eur Respir J, 2017, 49(1): 1601090.
|
| 35 |
中华医学会儿科学分会呼吸学组疑难少见病协作组，国家呼吸系统疾病临床医学研究中心，编辑委员会中华实用儿科临床杂志. 儿童原发性纤毛运动障碍诊断与治疗专家共识[J]. 中华实用儿科临床杂志，2018, 33(2): 94-99.
|
| 36 |
Brooks EA, Massanari M. Cost-effectiveness analysis of monitoring fractional exhaled nitric oxide (FeNO) in the management of asthma[J]. Manag Care, 2018, 27(7): 42-48.
|
| 37 |
Arnold RJ, Massanari M, Lee TA, et al. A review of the utility and cost effectiveness of monitoring fractional exhaled nitric oxide (FeNO) in asthma management[J]. Manag Care, 2018, 27(7): 34-41.
|